A couple has been trying for eighteen months. She has had her cycle mapped, hormones drawn across multiple phases, a pelvic ultrasound, an anti-Müllerian hormone (AMH) test, a thyroid panel, possibly a hysterosalpingogram, possibly a laparoscopy. He has had a conversation. Maybe.
Male factor accounts for somewhere in the range of 40-50% of infertility, either as the primary contributor or as half of a combined picture. A semen analysis costs a fraction of what any of the above costs, takes one sample, and is non-invasive in the most literal sense. The order of operations in most of these workups is backwards, and it stays backwards for reasons that have very little to do with clinical reasoning.
Before you begin
Is this for you?
This guide is for
- Men actively trying to conceive, or planning to within the next one to three years
- Men with a sub-reference semen analysis, an elevated follicle-stimulating hormone (FSH), a low testosterone, or a result they can't yet interpret
- Men currently on testosterone replacement who want children - this guide is written with you specifically in mind
- Men who want to understand their own reproductive physiology well enough to ask better questions, whether or not conception is imminent
This guide is not
- A replacement for fertility urology where the analysis is abnormal or a structural cause is suspected
- A reason to stop a prescribed medication on your own. Nothing here is an instruction to change what a prescriber has you on
Context
The other half of the equation
The female guide covers the ovarian, cyclical, and endometrial architecture, and it doesn't translate to a male-factor workup. As a partner, you'll get more from reading both. The practical overlap is larger than the differences: omega-3s, coenzyme Q10 (CoQ10), methylation status, glycemic control, sleep, and inflammatory load move both partners' parameters, and the cellular levers aren't gendered even where the anatomy is.
Your age belongs here too. It gets a fraction of the coverage maternal age gets, and it operates through a mechanistically distinct route - de novo mutation rate rises with paternal age because spermatogonial stem cells keep dividing across a lifetime and accumulate copying errors, where oocyte aging is a story about a fixed stock degrading. Different mechanism, different curve, and it shows up in outcomes that have nothing to do with whether conception happens. The curve is gradual rather than a cliff, but it's measurable - the de novo mutation count per sperm roughly doubles between a man in his twenties and a man past 40, and most of the literature on offspring outcomes starts showing an effect somewhere in the 40-45 range.
The mechanism
The biological foundation
Sperm production is a manufacturing line, and the line runs on a fixed schedule. Spermatogonial stem cells sit against the basement membrane of the seminiferous tubule and divide continuously - unlike the female stock, which was finalized before birth. A cell entering the process takes roughly 64 to 74 days to become a spermatozoon, and then another 10 to 14 days transiting the epididymis, where it acquires motility and the capacity to fertilize.
Two cell populations do the supporting work. Sertoli cells line the tubule, form the blood-testis barrier, and nurse each developing cohort through the sequence - FSH is the pituitary signal that speaks to them. Leydig cells sit outside the tubules in the interstitium and make testosterone in response to luteinizing hormone (LH). Those two signals do different jobs.
Timing
The seventy-four day window
Everything you do today shows up in a sample taken three months from now.
The batch being ejaculated this week entered production three months ago - it carries whatever oxidative load, thermal exposure, nicotine, cannabis, sleep debt, and micronutrient status was present then. Change something today and the sample in six weeks will be a blend of old batch and new. The clean read is at three months.
Two practical consequences follow. The first is that a bad result has a shelf life. A fever, a hot-tub habit, a stretch of terrible sleep, a course of illness - any of these can drop a count substantially, and the drop isn't a verdict on the man's fertility. It's a snapshot of conditions three months back. Before anyone builds a plan on a low result, look at the environment that produced it. That said, if you know the environment hasn't been the most conducive to a healthy sperm cycle, the simplest thing to do is correct what you already know is suboptimal and control for it.
The second is that the timeline for intervention is fixed and non-negotiable. Starting CoQ10 four weeks before an in vitro fertilization (IVF) cycle is starting it too late. If conception is on the horizon, the protocol warrants a start at least three months out. That's the length of the production cycle, plain and simple.
Reading the panel
What FSH and LH tell you that testosterone cannot
The panel to run is FSH, LH, total and free testosterone, sex hormone-binding globulin (SHBG), estradiol, prolactin, and a full thyroid panel. What makes it informative is the relationship between the variables rather than numbers in isolation.
Elevated FSH and LH alongside a low testosterone is a primary pattern - the pituitary is shouting and the testes aren't answering. The signal is being sent correctly and the tissue receiving it is underperforming. Elevated FSH specifically points at spermatogenic stress, because FSH is the Sertoli-cell signal and the Sertoli cells are the ones nursing the cohort.
Elevated FSH and LH alongside a normal total testosterone and a low free fraction (under 2%) is an androgen receptor or transport pattern - the pituitary is shouting and the testes are answering, but the free testosterone reaching circulation isn't enough to register as "enough" at the hypothalamus and pituitary. Fertility usually isn't affected significantly, though symptoms of low testosterone can still show up despite a serum total that reads adequate.
Low-to-normal LH and FSH alongside a low testosterone is a secondary pattern, and it's a different problem entirely - the signal isn't being sent in the first place. The testes may be perfectly capable. Head injury, opioid use, psychotropic medication, severe metabolic dysfunction, and pituitary lesions all live on this branch, as does a chronically elevated prolactin, which suppresses gonadotropin-releasing hormone (GnRH) upstream of everything.
SHBG distorts the reading. It binds testosterone out of circulation, so a high SHBG can produce a normal total testosterone sitting on top of a low free fraction. Where the total looks fine and the clinical presentation doesn't, free testosterone and SHBG can usually help resolve it.
Thyroid closes the panel, and thyroid-stimulating hormone (TSH) on its own doesn't cover it - in the same way just measuring FSH and LH doesn't work for testosterone status. TSH is the pituitary's message about thyroid status rather than a measure of what the tissue is receiving, so the panel to run is TSH together with free thyroxine (T4), free triiodothyronine (T3), reverse triiodothyronine (rT3), and, in some cases, thyroid antibodies. The free hormones show whether thyroid function is adequate and whether T4 is converting to the active form peripherally; antibodies can be positive while everything is in range, which is autoimmunity underway before the damage has impacted output.
Both directions of thyroid dysfunction impact fertility. An underactive thyroid tends to raise prolactin, and prolactin suppresses GnRH, which produces the secondary pattern: low LH and FSH with low testosterone. An overactive one raises SHBG, which binds testosterone out of circulation, and impairs motility in its own right. Thyroid hormone also acts directly on the Sertoli cells that nurse each developing cohort.
Replacement and fertility
The testosterone trap
Exogenous testosterone suppresses sperm production. The mechanism is straightforward: replacement doses provide the negative feedback the hypothalamus and pituitary are watching for, LH output falls, and the Leydig cells - which only make testosterone when LH tells them to - go quiet. Serum testosterone looks great, because it's being supplied from outside. Intratesticular testosterone collapses, because nothing is producing it locally, and spermatogenesis depends on it. Supply the signal from outside and the machinery that's supposed to generate it has no reason to keep working.
The result is a man with an excellent testosterone level on paper and a semen analysis that has fallen off a cliff. Somewhere between a substantial fraction and effectively all of production can shut down, depending on dose, duration, and the individual.
For the man reading this and feeling cornered: the restart is a managed sequence, not a cliff. The shape of it - and the specifics belong to a prescriber, not to a guide - is that replacement comes down, a SERM such as enclomiphene blocks the estrogen feedback at the hypothalamus so the gonadotropins climb back, intratesticular testosterone recovers, and spermatogenesis resumes over the following months. Human chorionic gonadotropin (hCG) works as an LH mimetic on the same problem from a different angle. In the protocols I've seen work, a low dose of exogenous testosterone often runs underneath the whole transition, specifically so the man doesn't spend six months feeling terrible while his axis comes back.
That last detail is why the absolute version of this rule - never testosterone if you want children - is wrong, and why I'll never write it that way. Protocols that restore fertility often include testosterone. The claim is narrower: replacement dosing, unaccompanied, is the wrong tool for this goal.
Secondary hypogonadism - a different problem, where the signal to make testosterone was never sent in the first place - presents the same way as replacement-driven suppression on a basic panel: low LH, low FSH. What tells the two apart is what appears beside those gonadotropins.
- Low LH and FSH beside a high or normal testosterone - exogenous suppression. Something is being taken.
- Low LH and FSH beside a low testosterone - secondary hypogonadism. The signal isn't being sent at all.
Read the gonadotropins, not the testosterone.
Recovery is usually good and it isn't universal. Longer duration of use, higher doses, and older age all lengthen the timeline, and a minority of men don't return to baseline. Where fertility is on the horizon, having the conversation before starting replacement is worth considerably more than having it afterward.
The outcome measure
The semen analysis
Hormones hint. The semen analysis tells you.
WHO 2021 lower reference limits
Those numbers are fifth-centile values derived from men whose partners conceived within twelve months - they describe the bottom edge of a fertile population, not a boundary between fertile and infertile. Men below them conceive. Men comfortably above them struggle. Treat a sub-reference result as information about probability and about what to change, not as a verdict.
Two additions help when the standard panel looks unremarkable and conception still isn't happening. DNA fragmentation index measures the integrity of the genetic payload rather than the appearance or movement of the cell - a man can have a textbook analysis and a high fragmentation index, and it associates with miscarriage and failed fertilization more than with failure to conceive. Thresholds vary by assay, so interpret it with the lab that ran it. Oxidative stress panels cover related ground.
At-home collection kits have made the first analysis considerably easier to obtain, and the analysis that never gets done is the failure mode I run into most often in this workup. Confirm anything abnormal with a repeat at two to three months.
Modifiable inputs
Environmental inputs
Four levers here, and the first is the highest-return free intervention in this guide.
The testes sit outside the body because spermatogenesis requires a temperature a few degrees below core. That arrangement is easy to defeat. Hot tubs, saunas, and a sustained fever have the strongest evidence behind them; heated car seats, a laptop resting on the lap, tight underwear, and long unsupported cycling raise scrotal temperature too, with a thinner literature behind the effect. A febrile illness or a regular hot-tub habit can drop a count for the better part of three months. Removing the heat source costs nothing and the effect is among the fastest available.
Nicotine, cannabis, and heavy alcohol each degrade count, motility, and morphology. Cannabis has a mechanism the other two don't: sperm carry cannabinoid receptors, and endocannabinoid signaling is involved in motility and in the acrosome reaction, so THC, the psychoactive compound in cannabis, acts on the cell directly rather than only through the axis. Recovery takes a production cycle - about three months - so the sooner you stop, the sooner the sperm being made reflect it. That's a reason to stop now, alongside trying, not to put trying off until the cycle has turned over. Antioxidant cover through those months is reasonable.
The common advice is to save up before the fertile window. Semen quality degrades after roughly two to three days of abstinence - motility and DNA integrity both fall as sperm sit in the epididymis accumulating oxidative exposure - so the saved-up sample is a larger volume of worse sperm. Intercourse every one to two days through the fertile window produces better parameters and better pregnancy rates than strategic abstinence does.
Moderate resistance and endurance training raises testosterone and improves semen parameters compared to sedentary life. The relationship isn't linear - a specific pocket of excessive endurance training (competitive cyclists, ultra-distance volume) is associated with lower sperm concentration and quality, likely through a mix of scrotal heat, mechanical trauma, and the same suppression of the hypothalamic-pituitary-gonadal (HPG) axis that shows up in other overtrained athletes. For most men reading this, the training problem is too little, not too much.
Upstream of the panel
Body composition and insulin
Body composition is upstream of the hormone panel, and it acts through two routes at once. Adipose tissue expresses aromatase, which converts testosterone to estradiol - so excess fat mass lowers testosterone and raises estradiol simultaneously, from a single mechanism. Separately, insulin resistance raises oxidative stress in the testis and impairs steroidogenesis directly. Fasting insulin and hemoglobin A1c (HbA1c) belong on the panel for this reason, not as general-health box-ticking.
Insulin resistance reaches well beyond the testis - it precedes type 2 diabetes by roughly a decade and drives the low testosterone picture in metabolically compromised men generally. If fasting insulin or HbA1c comes back elevated, the Metabolic Derailment guide covers the full mechanism and the protocol for reversing it.
High-sensitivity C-reactive protein (hs-CRP) is the systemic read on the inflammatory and oxidative burden this guide's levers - heat, substances, and the antioxidant stack - are working against. It won't move as fast as the semen parameters, but a falling number is corroborating evidence that the inputs are working.
Sleep is the lever men consistently underweight. The majority of daily testosterone production happens during sleep, tied to the overnight LH pulses - which means short or fragmented sleep isn't a background lifestyle variable here, it's a direct hit on the signal driving both testosterone and spermatogenesis. Seven hours, consistent timing. If sleep is the limiting factor, the sleep guide is a more useful document than this one.
Beyond the panel
Biopsychosocial fitness
Male reproductive fitness also depends on the nervous system, which doesn't reduce to a marker you can draw.
The axis as appraisal
The axis does more than hold a set point: it appraises circumstance and sets output to match. Production responds to sleep, to training load, to nutritional state, to whether challenge is being met, and to standing among other men. Read that way, a low number is often the body's appraisal of the position a man is in rather than a fault in the testes, which is the reason the men whose numbers move furthest on a protocol are usually the ones whose circumstances moved with them.
Men who report an earlier age at first intercourse tend toward worse long-term relational outcomes, not better - the opposite of what a purely reproductive account would predict. Shared genetic architecture produces both the earlier debut and the risk tolerance and impulsivity that go with it, which is why treating the timing as the cause misreads the finding.
Effort, reward, and the choice to have a child
Male reproductive effort rests on a trade between short and long horizons. Reward systems weighted toward novelty and immediacy tend to spend effort where it returns fastest; systems weighted toward delayed gratification accumulate the slower goods - skill, standing, a partner who stays. Sexual selection is the engine that historically pointed male effort at those slower goods. Most of what a young man builds, he builds to become selectable, whether or not he would put it that way.
Children are a further step down that same path, and a growing number of men don't take it - not from an inability to commit, but because the trade stops looking worth it from where they're standing. A partner who stays is reachable while staying flexible, keeping options open, chasing whatever looks interesting next. A child forecloses that, permanently. Many men can't picture wanting one until a partner makes the alternative concrete, and some don't want it even then, which is the same reward system weighing a known, permanent cost against a freedom it already holds.
Behavior, screens, and the axis
For fertility specifically, the pathways that carry mechanism rather than commentary are narrow. Alcohol and nicotine act on the parameters directly. Sleep displaced by late screens hits the overnight LH pulses. Novelty-seeking that crowds out training, daylight, and food quality reaches the axis through those same three inputs. Beyond that, the literature connecting these behaviors to semen parameters is thin, and I am not going to build a mechanism where the evidence has not.
If the panel is unremarkable, the analysis is unremarkable, and conception still isn't happening, the open question is whether the conditions the axis is appraising have changed - and whether the effort that once went toward skill, standing, and a partner who stays is going anywhere now.
The findable cause
Structural causes
Varicocele is the most common surgically correctable cause of male infertility - dilated veins in the pampiniform plexus impairing venous drainage, raising scrotal temperature, and increasing oxidative stress. It's present in a meaningful minority of men with abnormal parameters, and repair improves semen parameters in appropriately selected cases. Whether repair is indicated is a fertility-urology conversation, and it's worth having where the analysis is abnormal.
A testicular lesion described on imaging is a different category and warrants prompt urology follow-up on its own terms, independent of fertility.
Azoospermia - zero sperm on the analysis - is a different problem from a low count, not a more extreme version of it. The first branch point is whether it's obstructive - sperm are being made but can't get out, from a blockage, a vasectomy, or congenital bilateral absence of the vas deferens (CBAVD) - or non-obstructive, where production itself has failed. That distinction is usually made with FSH, testicular volume, and sometimes a genetic workup: karyotype to rule out Klinefelter syndrome (47,XXY), Y-chromosome microdeletion testing, and CFTR (cystic fibrosis gene) testing where the vas deferens can't be felt on exam. None of this changes diet or supplements. It changes whether sperm retrieval is surgical, whether a genetic counselor belongs in the conversation, and what a child conceived from that sperm might inherit.
Also ask about
The quieter causes
Infection is a quieter but findable cause to ask about directly - current or past epididymitis, orchitis (including a history of mumps after puberty), or an untreated sexually transmitted infection (STI) can all impair the parameters. A semen culture or a standard STI panel is a reasonable ask if nothing else on this page explains the result, and it's one of the few causes here that resolves completely once it's treated.
Other prescriptions affect the parameters too. Selective serotonin reuptake inhibitor (SSRI) antidepressants can affect ejaculation and, in some men, semen parameters. Finasteride and dutasteride (for hair loss or an enlarged prostate) have a more contested fertility literature, but it's worth raising if you're on one. A history of anabolic steroid use - distinct from a current prescription - can leave the axis suppressed well after stopping, on its own recovery timeline. Anyone with a chemotherapy or radiation history should have that flagged before any of the rest of this page gets acted on, since fertility preservation is a conversation that has a narrow window of its own.
The stack
The protocol
Everything below is available through the practitioner dispensary: Fullscript
Start with the foundation. Targeted additions work considerably better in a system that has been brought to nutritional sufficiency, and several of the targeted items are already inside a good combination product - check the label before stacking.
Foundation
A sperm-targeted multi covering zinc, selenium, CoQ10, carnitine, antioxidants, and folate in one product. This is the base of the stack. Zinc, copper, methylfolate, and CoQ10 in a good blend usually already land close to the targeted doses below - check the label before buying those four again. D3, N-acetylcysteine (NAC), and vitamin C typically run lighter in a blend than the targeted doses call for, so those three are worth adding rather than assuming covered.
Combined eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The sperm membrane is enriched in DHA, and omega-3 status correlates with motility and morphology. At 2-4 g/day it adds to the effect of anticoagulants and antiplatelet drugs, so that dose is a prescriber conversation if you're on one.
Often around 5,000 IU/day. Vitamin D receptors are expressed in the testis and on sperm itself. The reproductive target is above the standard deficiency cutoff, so test rather than guess - most men taking 1,000-2,000 IU don't reach it, and a comprehensive blend's D3 alone typically won't either.
Higher with a known methylenetetrahydrofolate reductase (MTHFR) variant, which is a conversation to have. Sperm DNA methylation depends on active folate, and homozygous MTHFR 677TT is over-represented in male infertility. Pairs with B12. Homocysteine is the marker that confirms the methylation support is landing - it climbs when folate and B12 aren't keeping pace, and it's on the retest panel for that reason.
Targeted
Started at least three months out. The sperm midpiece is dense with mitochondria, and motility is an energy problem.
Shuttles fatty acids into sperm mitochondria; a motility-specific addition that pairs with CoQ10.
Glutathione precursor supporting the antioxidant system that protects sperm DNA, and it helps semen viscosity. Most relevant where oxidative or inflammatory load is part of the picture.
With copper to balance. Zinc is rate-limiting for sperm production, count, morphology, and DNA stability. Long-term zinc without copper drives a copper deficiency, so keep them paired - and don't stack this on a blend that already contains both. The top of that range reaches the tolerable upper limit for zinc on its own, before counting anything already in the foundation blend - another reason not to stack it. Zinc also binds quinolone and tetracycline antibiotics in the gut and cuts their absorption, so separate the doses by a few hours.
Water-phase antioxidant concentrated in seminal plasma; cheap cover through a nicotine or cannabis cessation window specifically.
A potent antioxidant present in the testes, and it doubles as the sleep lever, which is itself moving testosterone. It adds to sedatives and sleep medication, so if you take either, the dose is a prescriber conversation.
A reproductive adaptogen supporting HPG coordination and libido under load.
RevolutionPRO · male formulation
What to track
What to track, and when
The retest window is three months, because that's the production cycle. Judging progress by feel inside that window will mislead you in both directions.
The outcome measure
The axis, at twelve weeks
Thyroid, the full panel
Confirming the protocol is landing
Metabolic and inflammatory markers
Prolactin once, fasting, and repeated fasting if elevated. TSH target at or below 2.5 mIU/L, read alongside the free hormones and the antibodies rather than on its own.
Take this with you
Questions for your provider
- We've been trying for a while - can we run or repeat a semen analysis, and should I see a fertility urologist?
- My FSH is elevated and/or my testosterone is low - is this a testicular or a brain-side cause? If testosterone is low and conception is the goal, can we use approaches that raise my own production - a SERM such as enclomiphene, or hCG - rather than replacement testosterone, which would suppress sperm?
- I'm currently on testosterone replacement and we want children. What does the transition look like, over what timeline, and what can we do so I don't feel terrible during it?
- Should I be evaluated for a varicocele?
- My prolactin is elevated - should we repeat it fasting and evaluate the pituitary?
- My TSH or thyroid antibodies suggest thyroid involvement - should we address it before conceiving, given the effect on motility?
- My standard analysis looks unremarkable and we still aren't conceiving - is DNA fragmentation testing worth adding?
Where this leaves you
The manufacturing line runs on a fixed schedule, and almost everything practical in this guide follows from that. It means a bad result is a report on a window that has already closed rather than a statement about you, and it means the levers you pull now are pulling on a batch that doesn't exist yet. That's the stance the whole series takes, laid out in full in the Ethos guide.
It also means a protocol has to start at least three months out, and the step to take today is a semen analysis. Both partners get the workup.
This guide is educational and isn't medical advice, diagnosis, or treatment. It doesn't replace the judgment of a licensed clinician who knows your history and your labs. Fertility care, hormone therapy, and the management of testosterone replacement are clinical decisions that carry real risks and require monitoring - nothing here is an instruction to start, stop, or change a prescribed medication on your own. Supplements can interact with medications and conditions; review any protocol with your clinician before starting, particularly if you're managing a medical condition or taking prescription medication. Biomarker panels and reference limits listed here are illustrative, not exhaustive, and reference ranges vary by assay and laboratory. Merlin may earn a commission on products purchased through the Fullscript link here.
Read this against your own results. Bring what you have - any lab, any year, any provider. Your first month reads your results together, every result against every other, and starts you where it matters most.
Start your first month - $35If you don't feel the value of Merlin after paying for your first month, tell us and we'll refund you in full. Monthly Core, once per person, by email within 30 days. The terms →
No results yet? Bring labs from anywhere, order our $180 baseline panel inside Merlin, or start with the questions, free.
Work with a practitioner. Some pictures want a second set of eyes and a plan you did not have to build yourself.
Start a conversation~ Your health data is never used to train AI. ~